or Try an Advanced Search...

    Technical Analysis for CAPR - Capricor Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 5.37 -1.65% -0.09
    CAPR closed down 1.65 percent on Wednesday, May 8, 2024, on 53 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical CAPR trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Support Bullish -1.65%
    Outside Day Range Expansion -1.65%
    Wide Bands Range Expansion -1.65%
    Crossed Above 20 DMA Bullish -2.89%
    MACD Bullish Signal Line Cross Bullish -2.89%
    NR7 Range Contraction -2.89%
    Narrow Range Bar Range Contraction -2.89%
    Inside Day Range Contraction -2.89%
    Older End-of-Day Signals for CAPR ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 13 hours ago
    10 DMA Support about 13 hours ago
    20 DMA Resistance about 18 hours ago
    Down 3% about 18 hours ago
    Fell Below Previous Day's Low about 18 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CAPR Chart by TradingView
    Basic chart:

    Profile

    Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics

    Is CAPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
    May 6 Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
    Apr 24 Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
    Apr 24 Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
    Apr 10 Wall Street Analysts Predict a 218.18% Upside in Capricor (CAPR): Here's What You Should Know
    Mar 25 How Much Upside is Left in Capricor (CAPR)? Wall Street Analysts Think 229.15%
    Mar 21 Capricor Therapeutics to Present at Upcoming Investor Conferences
    Mar 14 Earnings Beat: Capricor Therapeutics, Inc. (NASDAQ:CAPR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
    Mar 13 Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
    Mar 7 Can Capricor (CAPR) Climb 261.27% to Reach the Level Wall Street Analysts Expect?
    See more CAPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.2212
    52 Week Low 2.68
    Average Volume 369,780
    200-Day Moving Average 4.75
    50-Day Moving Average 5.82
    20-Day Moving Average 5.41
    10-Day Moving Average 5.36
    Average True Range 0.38
    RSI (14) 45.05
    ADX 19.26
    +DI 23.15
    -DI 22.29
    Chandelier Exit (Long, 3 ATRs) 5.61
    Chandelier Exit (Short, 3 ATRs) 5.83
    Upper Bollinger Bands 6.19
    Lower Bollinger Band 4.64
    Percent B (%b) 0.47
    BandWidth 28.71
    MACD Line -0.14
    MACD Signal Line -0.17
    MACD Histogram 0.0246
    Fundamentals Value
    Market Cap 165.36 Million
    Num Shares 30.8 Million
    EPS -1.16
    Price-to-Earnings (P/E) Ratio -4.63
    Price-to-Sales 8.72
    Price-to-Book 7.73
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.71
    Resistance 3 (R3) 5.71 5.59 5.65
    Resistance 2 (R2) 5.59 5.51 5.59 5.63
    Resistance 1 (R1) 5.48 5.45 5.54 5.48 5.62
    Pivot Point 5.37 5.37 5.39 5.37 5.37
    Support 1 (S1) 5.25 5.28 5.31 5.26 5.12
    Support 2 (S2) 5.14 5.23 5.14 5.11
    Support 3 (S3) 5.03 5.14 5.09
    Support 4 (S4) 5.03